Back to all Programs

Register here

Related Materials

Past event

Global HIV Clinical Forum 2016

Basic Science of Integrase Inhibitors - Mark Wainberg, MD

Clinical Case Discussion 1 - Pedro Cahn, MD, PhD

Resistance Characteristics of Integrase inhibitors - Charles Boucher, MD, PhD

Integrating Science Into The Clinic: Current and Future Use of Integrase Inhibitors - Anton Pozniak, MD, FRCP

Only the Best in Botswana - Optimizing the ART Response - Ava Avalos, MD

Optimizing HIV Therapy in Resource Limited Settings - François Venter, MD, FCP, PhD

Integrase strand-transfer inhibitors primary resistance in patients with acute/recent HIV infection - Juan Ambrosioni

Dolutegravir plus two nucleoside reverse transcriptase inhibitors versus efavirenz plus two nucleoside reverse transcriptase inhibitors as initial antiretroviral therapy for people with HIV: a systematic review - George Rutherford, MD, AM

Response to Raltegravir based third-line antiretroviral therapy among Ugandan children: A Case series from an urban HIV clinic - Victor Musiime, MBChB, MMED, PhD

Cross-resistance to integrase strand transfer inhibitors (INSTIs) in 23 multiexperienced Mexican patients failing to raltegravir - Aurelio Orta-Reséndiz, MD, MSc

Pharmacological Considerations & Clinical Case Discussion - Anna Maria Geretti, MD, PhD, FRCPath

Future Challenges of HIV treatment - Stefano Vella, MD

HIV Therapy in Populations with Unique Challenges – Pediatrics - Victor Musiime, MBChB, MMED, PhD